General Atlantic, L.P.
General Atlantic, L.P. reported 12 US-listed holdings worth $2.91 billion in its 13F for the quarter ended 30 June 2026, filed 14 August 2026. Its largest: Liftoff Mobile Inc. Com (20.9%), Dlocal Ltd (20.9%) and Chime Finl Inc (15.0%). Against the quarter before, it opened 3 positions, added to 1, trimmed 3 and sold out of 3.
Reported holdings$2.91B+35.3% on Q1 2026
Positions12as many as Q1 2026
The largest ten99.0%of its reported holdings
Latest 13FQ2 2026filed 14 August 2026
OpenedAdded toHeldTrimmed
The 12 largest of its 12 positions, each sized by its share of the reported holdings, coloured by the change in shares against Q1 2026.
What the fund reported holding at each quarter's end; hover a bar for the number of positions
What it did on the quarter
Opened 3Added 1Held 5Trimmed 3Sold out 3
Its positions against its 13F for the quarter to 31 March 2026; a change under 0.1% of a position counts as held
Opened 3
- Liftoff Mobile Inc. Com LFTO$608.1 million
- Seaport Therapeutics Inc. SPTX$132.5 million
- Parabilis Medicines Inc. Com PBLS$42.1 million
Added to 1
- Alkami Technology Inc. ALKT+4.0 million shares · +26%
Trimmed 3
- Revolution Medicines, Inc. RVMD-350,000 shares · -49%
- Pharvaris N V PHVS-1.5 million shares · -18%
- Nurix Therapeutics Inc. NRIX-1.1 million shares · -26%
Sold out of 3
- European Wax CTR Inc. EWCZ$75.8 million last quarter
- Centessa Pharmaceuticals PLC CNTA$53.8 million last quarter
- Webull Corp. BULL$243,917 last quarter
What it holds
| Company | Shares | Value | Of its book | Change in shares |
|---|---|---|---|---|
| Liftoff Mobile Inc. Com LFTO | 25,315,646 | $608.1 million | 20.92% | new |
| Dlocal Ltd DLO | 46,656,695 | $606.3 million | 20.86% | no change |
| Chime Finl Inc CHYM | 21,259,683 | $435.4 million | 14.98% | no change |
| Alkami Technology Inc. ALKT | 19,379,038 | $351.1 million | 12.08% | +4,041,543 |
| XP Inc. XP | 20,566,133 | $334.4 million | 11.50% | no change |
| Pharvaris N V PHVS | 6,550,757 | $226.5 million | 7.79% | -1,480,495 |
| Seaport Therapeutics Inc. SPTX | 6,101,582 | $132.5 million | 4.56% | new |
| Nurix Therapeutics Inc. NRIX | 3,032,185 | $73.6 million | 2.53% | -1,069,680 |
| Revolution Medicines, Inc. RVMD | 357,791 | $67.0 million | 2.31% | -350,000 |
| Parabilis Medicines Inc. Com PBLS | 1,538,461 | $42.1 million | 1.45% | new |
| Riskified Ltd RSKD | 5,324,998 | $26.8 million | 0.92% | no change |
| Grove Collaborative Hold Inc. GROV | 2,474,859 | $3.1 million | 0.11% | no change |
Every US-listed position in the fund's 13F for the quarter ended 30 June 2026, by the value it reported.